Elucid AI-PREDICT study begins testing lesion-level heart attack risk with CCTA
Elucid’s AI-PREDICT study will test whether CCTA plaque analysis can identify the coronary lesions most likely to cause a heart attack.
Medical Devices & Diagnostics